IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: IMS Health-BLOCK
Symbol: IMS
Price: Last trade $32.10
Trade Date: 8/6
Shares: 20 million
Underwriter(s) J.P. Morgan, Morgan Stanley
Rating=Subscription Needed
Company: Surgical Care Affiliates, Inc.-BLOCK
Symbol: SCAI
Price: Last trade $38.59
Trade Date: 8/6
Shares: 4 million
Underwriter(s) Citigroup
Rating=Subscription Needed
Secondaries announced 8.5.2015